Abstract
e21029 Background: The global, randomized, Phase III ToGA study showed that trastuzumab (H) plus capecitabine or 5-fluorouracil and cisplatin (XP/FP) significantly improves overall survival (OS) vs...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have